Ivermectin for Long Vax

In the wake of the largest inoculation campaign ever, the negative aftereffects many individuals are continuing to experience post-vaccination are increasingly being referred to as “Long Vax.”

This term characterizes a range of persistent symptoms that, while mirroring the widely recognized Long Covid, are distinct in their attribution solely to the vaccine’s aftermath in vaccinated individuals. Amidst this backdrop, the search for effective interventions has led to a focus on Ivermectin as a potential remedy for those grappling with Long Vax conditions.

Clarifying Long Vax

“Long Vax” encapsulates the experiences of individuals facing lingering symptoms following their vaccination, including but not limited to fatigue, brain fog, joint pains, and autonomic disturbances. Long Vax symptoms are reported exclusively by those who have received the vaccine, leading to a pressing discourse on vaccine-related side effects versus the expected post-infection sequelae.

The emergence of the term “Long Vax” signifies a growing acknowledgment of these vaccinated individuals’ experiences, driving a distinction in how the medical community approaches, diagnoses, and treats these persisting conditions. The challenge lies in disentangling these symptoms’ etiology, with ongoing research aimed at understanding whether they stem directly from the vaccine’s immunological impact or represent a complex interplay of factors triggered by the vaccination.

Exploring Ivermectin’s Potential

Ivermectin has ventured into the limelight amidst the supposed pandemic, initially proposed as a potential antiviral agent. This has extended into the realm of treating Long Vax symptoms, fueled by reports and research advocating for its efficacy in alleviating these conditions. The mechanism behind Ivermectin’s beneficial effects for Long Vax sufferers involves its ability to bind with the same receptors that the toxins in the vaccine also bond with. By replacing the toxins and pushing them out into the blood, they can more easily be broken down and excreted by the body.

Ivermectin’s anti-inflammatory capabilities and its potential to modulate the immune response may also be a factor in the efficacy of this wonder drug. This dual action could theoretically address the underlying immune dysregulation speculated to contribute to the persistence of Long Vax symptoms.

Patient Experiences and Doctor Observations

Among those who report improvement in Long Vax symptoms with Ivermectin, stories range from mild alleviation of symptoms to significant recoveries. Doctors treating Long Vax patients with Ivermectin note varied responses, with the overwhelming majority observing noticeable improvements in fatigue levels, cognitive function, and overall wellbeing.

In our own experiences here at FirstMed Inc, we have seen improvement in every single one of our patients using Ivermectin in conjunction with zinc and several other heath supplements that we use in our vaccine detox protocol. We have helped people recover from conditions as serious as full paralysis of both legs, arms, and even facial paralysis – which the patients had been suffering from for month before they came to us for treatment.

In all the cases where we have treated people with severe vaccine injury, we have noticed an improvement of their condition usually within the first few days, but if not almost always within the first week. We are not alone in our observations, with many doctors we work with or are in regular contact with, noting the same thing.

Patient forums and support groups have become pivotal for many sufferers in sharing experiences and strategies for managing Long Vax, with Ivermectin frequently discussed as a part of individual treatment journeys. These personal narratives contribute to a collective demand for further investigation into post-vaccination conditions and the potential of Ivermectin as a treatment.

The Path Forward with Research and Understanding

The emergence of Long Vax as a recognized condition within the post-vaccination landscape signals a critical need for dedicated research efforts. Understanding the mechanisms driving Long Vax symptoms, the role of immune system dysregulation, and the potential therapeutic targets are paramount.

As the medical community navigates these uncharted waters, collaboration between researchers, clinicians, and patients is crucial. Transparent communication of research findings, coupled with patient-centered care models, will ensure that the journey towards understanding and treating Long Vax is both evidence-based and empathetic.

Conclusion

Long Vax represents a complex, multifaceted challenge in the aftermath of the bungled pandemic response, intertwining medical, scientific, political, and societal threads. Ivermectin, at the center of current discourse as a potential treatment, embodies the broader quest for answers and relief for those affected.

Here at FirstMed, we will continue to treat patients with Ivermectin as long as we can clearly see the positive effects it is having on our patients and customers. While we do not know the long-term implications of the vaccines, we do know that Ivermectin can provide relief – at least in the medium term – while more research is done to understand the mistakes that were made and what can be done to fix this situation in entirety.